Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide

NCT00272948 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

360

Enrollment

NETWORK

Sponsor class

Conditions

Hepatic Veno-Occlusive Disease

Interventions

DRUG: Defibrotide
DRUG: Defibrotide
DRUG: Defibrotide

Sponsor

European Society for Blood and Marrow Transplantation

Collaborators

[object Object]
[object Object]